Pere Santamaria
Grupo de investigación
- Patogenia y tratamiento de la autoinmunidad Group leader (R4)
Publicaciones destacadas
-
Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders
Autores:Referencia: Immunology 2020. -
Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity
Autores:Referencia: Journal Of Clinical Investigation 2020. -
Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules
Autores:Referencia: Nature Communications 2019. -
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
Autores:Referencia: Nature Communications 2019. -
Antigen-specific therapeutic approaches for autoimmunity
Autores:Referencia: Nature Biotechnology 2019. -
Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
Autores:Referencia: Journal Of Experimental Medicine 2019. -
In vivo clearance of nanoparticles by transcytosis across alveolar epithelial cells
Autores:Referencia: Plos One 2019. -
Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity
Autores:Referencia: Acs Nano 2018. -
Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.
Autores:Referencia: European Journal Of Immunology 2018. -
A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress Colitis
Autores:Referencia: Cell 2017.